Search For "covishield"
SEC asks for more data to grant full market approval to Covaxin and Covish
Updated : 4 years, 2 months ago IST
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources
Read More
Jharkhand man paralysed for four years says he is able to move and speak a
Updated : 4 years, 2 months ago IST
Bokaro (Jharkhand) [India], January 14 (ANI): A 55-year-old man, who had become paralysed and lost his voice four years ago in an accident, said he was able to move and speak after he was given Covishield vaccine on January 4.
Read More
DCGI's SEC to review applications of Bharat Biotech, SII for full market a
Updated : 4 years, 2 months ago IST
New Delhi [India], January 14 (ANI): Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said.
Read More
Facing vaccine shortage; no indication of flattening of curve: Maha Health
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 13 (ANI): Maharashtra is facing a shortage of Covaxin and Covishield, said state health minister Rajesh Tope on Thursday.
Read More
COVID-19 precautionary dose will be same vaccine administered previously:
Updated : 4 years, 2 months ago IST
New Delhi [India], January 5 (ANI): The precautionary COVID-19 vaccine dose, which is to be given to healthcare and frontline workers, and those over 60 years of age with co-morbidities from January 10, will be the same vaccine as administered previously in the first two doses, said Dr VK Pa
Read More
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID boos
Updated : 4 years, 2 months ago IST
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav
Read More
Centre rejects reports of expired COVID-19 vaccines being administered in
Updated : 4 years, 2 months ago IST
New Delhi [India], January 3 (ANI): Media reports claiming that expired vaccines are being administered in India are false and misleading, stated a Ministry of Health and Family Welfare release on Monday.
Read More
India's vaccination coverage crosses 142.47 crore
Updated : 4 years, 2 months ago IST
New Delhi [India], December 28 (ANI): With the administration of 72.87 lakh (72,87,547) vaccine doses in the last 24 hours, India's COVID-19 vaccination coverage has exceeded 142.47 crore crore (1,42,46,81,736) as per provisional reports till 7 am on Tuesday.
Read More
Lancet study stating that protection offered by Covishield declines after
Updated : 4 years, 3 months ago IST
New Delhi [India], December 23 (ANI): The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
Read More
COVID-19: Andaman and Nicobar Islands achieve 100 pc vaccination coverage
Updated : 4 years, 3 months ago IST
Port Blair (Andaman and Nicobar Islands) [India], December 19 (ANI): Andaman and Nicobar Islands achieved 100 per cent double-dose COVID-19 vaccination coverage, becoming the first State/UT to achieve the milestone using only Covisheild, informed the Andaman and Nicobar Islands Administra
Read More
Subject Expert Committee to meet tomorrow to discuss approval for Covishie
Updated : 4 years, 3 months ago IST
New Delhi [India], December 9 (ANI): The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) will hold the first meeting on Friday regarding the COVID-19 booster dose, said sources on Thursday.
Read More
COVID-19: Allow booster dose for healthcare, front line workers, writes Te
Updated : 4 years, 3 months ago IST
Hyderabad (Telangana) [India], December 4 (ANI): Telangana Health Minister T Harish Rao on Friday wrote to Union Health Minister Mansukh Mandaviya to reduce the gap between the two doses of Covishield and allow booster dose for frontline workers in view of emerging COVID-19 variants.
Read More